CONTACT US
Thanks for your interest in Re-Vana! If you have questions, comments, or would like to talk about our products, please fill out the information below and we’ll contact you as soon as possible.
CONTACT US
United Kingdom
T: +44 (0) 28 9097 5814
E: info@re-vana.com
USA
T: +1 (813) 323 1438
E: mor.revana@gmail.com
Mailing
Re-Vana Therapeutics Ltd
McClay Research Centre
97 Lisburn Road
Belfast, BT9 7BL
United Kingdom
Re-Vana Therapeutics Inc.
1027 South Dakota Ave
Tampa, FL 33606
USA
Our Products
EyeLief™
EyeLief™ is a novel photocrosslinked sustained-release preformed biodegradable implant delivering large and small therapeutics for 4-6 months or more.
OcuLief™
PARTNERSHIPS
Re-Vana collaborates and is open to business development partnerships to deliver both small and large molecules with our technology platforms.
To discuss please contact Michael O’Rourke CEO on (+1) 813 323 1438 (Tampa Florida) or mor.revana@gmail.com
NICOX ENTERS RESEARCH COLLABORATION WITH RE-VANA THERAPEUTICS
Re-Vana's technology offers us additional opportunities, alongside our recently announced collaboration with pSivida, to explore the potential for sustained-release delivery of our novel, next generation of stand-alone NO-donors. EyeLief(TM) technology has a number of unique properties that have shown promise in the delivery of drugs for the reduction of IOP. We look forward to working with Re-Vana on this innovative research endeavor.RE-VANA'S DESIGN STRATEGY
CONTACT US
United Kingdom
T: +44 (0) 28 9097 5814
E: info@re-vana.com
USA
T: +1 (813) 323 1438
E: mor.revana@gmail.com
Mailing
Re-Vana Therapeutics Ltd
McClay Research Centre
97 Lisburn Road
Belfast, BT9 7BL
United Kingdom
Re-Vana Therapeutics Inc.
1027 South Dakota Ave
Tampa, FL 33606
USA